Opioid Maintenance Medications Comparison Study
NCT00344812 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 220
Last updated 2006-06-27
Summary
A 17 week, double-blind, randomized, parallel group, four arm design outpatient study comparing LAAM, buprenorphine and two dose levels of methadone for the treatment of opioid dependence.
Conditions
- Opioid Dependence
Interventions
- DRUG
-
LAAM. buprenorphine and methadone
Sponsors & Collaborators
- lead OTHER
Principal Investigators
-
Rolley E Johnson, PharmD · Johns Hopkins University
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- DOUBLE
- Model
- PARALLEL
Eligibility
- Min Age
- 21 Years
- Max Age
- 55 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 1996-01-31
- Completion
- 1998-06-30
Countries
- United States
Study Locations
More Related Trials
-
Opioid Agonist and Antagonist Effects on Opioid Dependence
NCT00142727 ·Status: TERMINATED ·Phase: PHASE2
-
Alternate Day Buprenorphine Administration, Phase IX - 14
NCT00000232 ·Status: COMPLETED ·Phase: PHASE2
-
A Pragmatic Randomized Control Trial Comparing Models of Care in the Management of Prescription Opioid Misuse
NCT03033732 ·Status: COMPLETED ·Phase: PHASE4
-
Buprenorphine and Methadone for Opioid-dependent Chronic Back Pain Patients
NCT01559454 ·Status: COMPLETED ·Phase: PHASE4
-
Alternate-Day Buprenorphine Administration. Phase VI - 7
NCT00000225 ·Status: COMPLETED ·Phase: PHASE2
-
Multicenter Clinical Trial of Buprenorphine - 3
NCT00000207 ·Status: COMPLETED ·Phase: PHASE3
-
Open-Label, Safety Study of Lofexidine
NCT02363998 ·Status: COMPLETED ·Phase: PHASE3
-
Buprenorphine Physician-Pharmacist Collaboration in the Management of Patients With Opioid Use Disorder: CTN 0075
NCT03248947 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Prescription Opioid Addiction Treatment Study (POATS)
NCT00316277 ·Status: COMPLETED ·Phase: PHASE3
-
Extended-release Pharmacotherapy for Opioid Use Disorder
NCT05164549 ·Status: COMPLETED ·Phase: PHASE3
-
Buprenorphine Treatment: A Safe Alternative for Opioid Dependent Pain Patients
NCT01841931 ·Status: TERMINATED ·Phase: PHASE4
-
Identifying Optimal Buprenorphine Dosing for Opioid Use Disorder Treatment and Prevention of Overdose
NCT06316830 ·Status: RECRUITING ·Phase: PHASE2/PHASE3
-
Buprenorphine/Naloxone Treatment for Opioid Dependence-Experiment III) - 3
NCT00000328 ·Status: WITHDRAWN ·Phase: PHASE2
-
Alternate-Day Buprenorphine Administration. Phase IV - 5
NCT00000223 ·Status: COMPLETED ·Phase: PHASE2
-
Buprenorphine Treatment for Opioid Dependence
NCT02187198 ·Status: COMPLETED ·Phase: PHASE3
-
Alternate-Day Buprenorphine Administration. Phase II - 4
NCT00000222 ·Status: COMPLETED ·Phase: PHASE1
-
Optimizing Outcomes Using Suboxone for Opiate Dependence
NCT00591617 ·Status: COMPLETED ·Phase: NA
-
A Within Subject Comparison of Opioid Withdrawal in Opioid Dependent Individuals
NCT01136356 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Pharmacokinetic & Pharmacodynamic Interaction of Lofexidine and Buprenorphine in Buprenorphine Maintained Patients
NCT01820442 ·Status: COMPLETED ·Phase: PHASE1
-
Efficacy, Safety and Dose-Response Study Followed by Open-Label Study of Lofexidine Treatment of Opioid Withdrawal
NCT01863186 ·Status: COMPLETED ·Phase: PHASE3
-
Ketamine for Opioid Use Disorder
NCT06943859 ·Status: RECRUITING ·Phase: PHASE2
-
PO Methadone Ortho Outpatient
NCT06351215 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3
-
Study of the Treatment of Experimental Pain in Buprenorphine Maintained Persons With Chronic Musculoskeletal Pain
NCT02372591 ·Status: COMPLETED ·Phase: PHASE1
-
Buprenorphine/Naloxone for Treatment of Opiate Dependence - 9
NCT00000344 ·Status: COMPLETED ·Phase: PHASE2
-
Low-dose Buprenorphine Initiation for Opioid Use Disorder
NCT05450718 ·Status: RECRUITING ·Phase: PHASE4